Condition
CD123+ Acute Myeloid Leukemia clinical trials and research
As of November 12, 2026, Find a Trial lists 2 CD123+ Acute Myeloid Leukemia clinical trials that are recruiting, at sites in 2 countries (most in United States (1), China (1)). By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
ORM-1153 for CD123+ AML: a first-in-human dose study
ThisPhase 1 trial tests whether ORM-1153 is safe and may help some adults with CD123-positive AML.
-
Immunotherapy using modified NK cells for treating relapsed or refractory AML
This study is testing a new treatment using modified immune cells to see if it can help people with relapsed or hard-to-treat Acute Myeloid Leukemia feel better and achieve remission.
Related topics
Quick answers
How many CD123+ Acute Myeloid Leukemia clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.